Please try another search
BGI Genomics Co Ltd is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as drugs basic research and clinical application services. The Company mainly provides services for domestic and overseas academic institutions, research institutes, independent laboratories, pharmaceutical companies, hospitals and medical institutions, among others. The Company mainly operates its businesses in domestic market.
Name | Age | Since | Title |
---|---|---|---|
Jian Wang | 68 | - | Chairman |
Ye Yin | 43 | 2015 | Vice Chairman of the Board |
Lijian Zhao | - | - | Director and General Manager |
Lijian Zhao | 47 | 2021 | GM & Director |
Yutao Du | 46 | 2018 | COO, Deputy GM & Director |
Yu Jie Hu | 40 | 2015 | Member of Supervisory Board |
Ning Li | 43 | 2023 | Deputy GM & Director |
Hongtao Wang | 50 | 2016 | Director |
Leroy E. Hood | 85 | 2017 | Member of Scientific Advisory Board |
Lan Du | 48 | 2021 | Independent Director |
Ya Cao | 73 | 2021 | Independent Director |
Siqi Liu | 71 | 2021 | Chairman of the Supervisory Board |
Jinfeng Zhang | 42 | 2022 | Supervisor |
Lisheng Yu | 51 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review